Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Commentary

Potential Health Risks From Beverages Containing Fructose Found in Sugar or High-Fructose Corn Syrup

  1. George A. Bray, MD⇓
  1. Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana
  1. Corresponding author: George A. Bray, brayga{at}pbrc.edu.
Diabetes Care 2013 Jan; 36(1): 11-12. https://doi.org/10.2337/dc12-1631
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Fructose is a sweet tasting sugar that is found naturally in fruits and some vegetables and has been part of the human diet—in modest amounts—for eons. The increasing consumption of sugar has dramatically increased our exposure to fructose (1). Sugar consumption has risen more than 40-fold since the Declaration of Independence was signed 250 years ago, and more than 40% of the added sugars in our diet are in sugar-sweetened beverages and fruit drinks (2,3). Thus, the principal sources of fructose in our diet are now sugar and high-fructose corn syrup, each of which has about 50% fructose. The intake of soft drinks has risen fivefold since 1950 (4,5) (Fig.1) and with it the intake of fructose. The rise in the consumption of high-fructose corn syrup in beverages has paralleled the rise in the prevalence of obesity and the metabolic syndrome and is associated with the appearance of nonalcoholic fatty liver disease (6–8). Although association does not prove causation, it has stimulated research to understand whether current levels of fructose intake in beverages pose a health risk.

Background

Over the past decade fructose from either sucrose or high-fructose corn syrup has received growing attention as it has been associated with a widening group of health-related problems. Several meta-analyses have shown a relationship between the consumption of sugar-sweetened soft drinks and obesity (9–11). The relation of these beverages to obesity can be attributed to the increased caloric intake and to the fact that beverages do not suppress the intake of other foods to an appropriate degree—thus beverage calories serve as “add-on” calories enhancing the risk of obesity (12) (Fig. 1). Meta-analyses have also suggested that the consumption of sugar-sweetened beverages is related to the risk of diabetes, the metabolic syndrome, and cardiovascular disease (13).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Model showing some potential consequences of increasing fructose and energy intake from sugar or high-fructose corn syrup in beverages. VAT, visceral adipose tissue.

Several short-term clinical trials have provided insights into the metabolic consequences of ingesting sugar-sweetened beverages. In one study there was an increase in body weight, blood pressure, and inflammatory markers (14,15), and in a second study there was an increase in triglycerides levels (particularly at night), a stimulation of de novo lipogenesis, and an increase in visceral fat (16,17). In the third study, which compared milk, diet cola, a sugar-sweetened cola, and water, the sugar-sweetened beverage increased liver fat, visceral fat, and triglycerides over the 6 months of beverage intake (18). The latter study suggests that consuming two 16-ounce sugar-containing beverages per day for 6 months can mimic many of the features of the metabolic syndrome and nonalcoholic fatty liver disease.

Brief overview

The article by Aeberli et al. (19) in this issue of Diabetes Care and their previous study (20) have added important data on the responses to fructose. They conducted a 4-week randomized crossover study with a 4-week wash-out between each diet in 9 healthy young men comparing 4 different soft drinks with levels of fructose, glucose, and sucrose that are closer to “normal” intake than some other studies. The low-fructose beverage had 40 g per day of fructose, which was the same amount of fructose as in the 80 g per day sucrose beverage (40 g). This is less fructose than is contained in two 16-ounce sugar-sweetened soft drinks with 10% sugar. There was also a high-glucose beverage (80 g per day), which is twice what was in the sucrose beverage, and an 80 g per day fructose beverage, which is also twice the amount in the sucrose and low-fructose beverages. With the hyperinsulinemic-euglycemic clamp, the authors examined insulin sensitivity of the liver and the whole body. Compared with the high-glucose beverage, the low-fructose beverage impaired hepatic insulin sensitivity, but not whole-body insulin sensitivity, pointing again to the pathophysiological effects that fructose can have on the liver. In addition, they found that total and LDL cholesterol were increased by fructose relative to glucose and that free fatty acids were increased or showed a trend toward an increase in the fructose beverage groups.

This article has several strengths, one of which is that it is a randomized crossover comparison of four beverages with two levels of fructose, glucose, and sucrose (50% fructose). Another strength is that the study used modest amounts of fructose and had a glucose control. One limitation is that it had only a small number of subjects and that they were all male, so we cannot be absolutely sure that these results extrapolate to females.

The authors did not find any effect on fasting triglycerides. However, they did not design the study to look at postprandial or nocturnal levels of triglycerides where they might have detected differences. In the comparison of the effect of glucose, fructose, and sucrose on plasma triglycerides, Cohen and Schall (21) found that both fructose in the amount found in sucrose AND sucrose increased triglycerides following a meal, but that glucose did not—leading them to conclude that the effects on lipids were due to the fructose either alone or as part of sucrose (table sugar), and not glucose.

This study adds to the information about the role of fructose either from sucrose (ordinary table sugar) or from high-fructose corn syrup in initiating liver dysfunction and possibly leading to nonalcoholic fatty liver disease and the metabolic syndrome, which have become increasingly prevalent. Figure 1 relates the findings from this study to those of other studies (13,16–18,22). The increasing intake of soft drinks (4,5) is viewed as the driver for the increase in energy and fructose, which may play a part in the development of obesity and the metabolic consequences depicted here (22). The caffeine present in these beverages is viewed as a positive feedback signal because of its ability to stimulate the central nervous system.

Two other meta-analyses of crystalline fructose added to the diet appeared to reach different conclusions. Livesey and Taylor (23) and Sievenpiper et al. (24) examined the effects of replacing carbohydrates in the diet with crystalline fructose. Both excluded high-fructose corn syrup and thus the beverage form of fructose, which seems to play the central role in the response to the fructose in beverages. Crystalline fructose added to the food supply represents only a few percent of the total “added sugars” and behaves differently from the fructose that is in beverages. The largest amount of dietary fructose comes from the fructose in sucrose or high-fructose corn syrup, both of which are the major components of calorie-sweetened beverages but were excluded from these meta-analyses.

One key question which Aeberli et al. begin to address is whether the detrimental effects of fructose are simply the result of a linear dose-response to our increasing dietary intake of fructose or whether there is a threshold below which fructose is without harm. The current data suggest that it is a “linear” response, and the reason we are now detecting the pathophysiological consequences of fructose is that its dietary load has continued to increase, largely as a consequence of increased soft drink and fruit drink consumption.

Acknowledgments

No potential conflicts of interest relevant to this article were reported.

Footnotes

  • See Aeberli et al., p. 150

  • © 2013 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

References

  1. ↵
    1. Havel PJ
    . Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005;63:133–157pmid:15971409
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Vos MB,
    2. Kimmons JE,
    3. Gillespie C,
    4. Welsh J,
    5. Blanck HM
    . Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med 2008;10:160pmid:18769702
    OpenUrlPubMed
  3. ↵
    1. Marriott BP,
    2. Olsho L,
    3. Hadden L,
    4. Connor P
    . Intake of added sugars and selected nutrients in the United States, National Health and Nutrition Examination Survey (NHANES) 2003-2006. Crit Rev Food Sci Nutr 2010;50:228–258pmid:20301013
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Duffey KJ,
    2. Popkin BM
    . Shifts in patterns and consumption of beverages between 1965 and 2002. Obesity (Silver Spring) 2007;15:2739–2747pmid:18070765
    OpenUrlCrossRefPubMed
  5. ↵
    Putnam JJ, Allshouse JE. Food Consumption, Prices and Expenditure, 1970-1997. U.S. Department of Agriculture Food and Rural Economics Division, Economic Research Service Bulletin, No. 965, p. 34
  6. ↵
    1. Bray GA,
    2. Nielsen SJ,
    3. Popkin BM
    . Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004;79:537–543pmid:15051594
    OpenUrlAbstract/FREE Full Text
    1. Bray GA
    . How bad is fructose? Am J Clin Nutr 2007;86:895–896pmid:17921361
    OpenUrlFREE Full Text
  7. ↵
    1. Dekker MJ,
    2. Su Q,
    3. Baker C,
    4. Rutledge AC,
    5. Adeli K
    . Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010;299:E685–E694pmid:20823452
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Vartanian LR,
    2. Schwartz MB,
    3. Brownell KD
    . Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health 2007;97:667–675pmid:17329656
    OpenUrlCrossRefPubMedWeb of Science
    1. Olsen NJ,
    2. Heitmann BL
    . Intake of calorically sweetened beverages and obesity. Obes Rev 2009;10:68–75pmid:18764885
    OpenUrlCrossRefPubMed
  9. ↵
    1. Malik VS,
    2. Willett WC,
    3. Hu FB
    . Sugar-sweetened beverages and BMI in children and adolescents: reanalyses of a meta-analysis. Am J Clin Nutr 2009;89:438–439; author reply 439–440pmid:19056589
    OpenUrlFREE Full Text
  10. ↵
    1. Mourao DM,
    2. Bressan J,
    3. Campbell WW,
    4. Mattes RD
    . Effects of food form on appetite and energy intake in lean and obese young adults. Int J Obes (Lond) 2007;31:1688–1695pmid:17579632
    OpenUrlCrossRefPubMed
  11. ↵
    1. Malik VS,
    2. Popkin BM,
    3. Bray GA,
    4. Després JP,
    5. Willett WC,
    6. Hu FB
    . Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010;33:2477–2483pmid:20693348
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Raben A,
    2. Vasilaras TH,
    3. Møller AC,
    4. Astrup AA
    . Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr 2002;76:721–729pmid:12324283
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Sørensen LB,
    2. Raben A,
    3. Stender S,
    4. Astrup A
    . Effect of sucrose on inflammatory markers in overweight humans. Am J Clin Nutr 2005;82:421–427pmid:16087988
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Stanhope KL,
    2. Schwarz JM,
    3. Keim NL,
    4. et al
    . Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322–1334pmid:19381015
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Stanhope KL,
    2. Bremer AA,
    3. Medici V,
    4. et al
    . Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J Clin Endocrinol Metab 2011;96:E1596–E1605pmid:21849529
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Maersk M,
    2. Belza A,
    3. Stødkilde-Jørgensen H,
    4. et al
    . Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 2012;95:283–289pmid:22205311
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Aeberli I,
    2. Hochuli M,
    3. Gerber PA,
    4. et al
    . Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial. Diabetes Care 2013;36:150–156
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Aeberli I,
    2. Gerber PA,
    3. Hochuli M,
    4. et al
    . Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr 2011;94:479–485pmid:21677052
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Cohen JC,
    2. Schall R
    . Reassessing the effects of simple carbohydrates on the serum triglyceride responses to fat meals. Am J Clin Nutr 1988;48:1031–1034pmid:3048075
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Welsh JA,
    2. Sharma A,
    3. Abramson JL,
    4. Vaccarino V,
    5. Gillespie C,
    6. Vos MB
    . Caloric sweetener consumption and dyslipidemia among US adults. JAMA 2010;303:1490–1497pmid:20407058
    OpenUrlCrossRefPubMed
  21. ↵
    1. Livesey G,
    2. Taylor R
    . Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 2008;88:1419–1437pmid:18996880
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Sievenpiper JL,
    2. de Souza RJ,
    3. Mirrahimi A,
    4. et al
    . Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 2012;156:291–304pmid:22351714
    OpenUrlCrossRefPubMed
Back to top
Diabetes Care: 44 (3)

Current Issue

March 2021
Volume 44, Issue 3

  • Current Issue
  • Index by Author
  • Issue Archive
  • Podcasts
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Potential Health Risks From Beverages Containing Fructose Found in Sugar or High-Fructose Corn Syrup
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Potential Health Risks From Beverages Containing Fructose Found in Sugar or High-Fructose Corn Syrup
George A. Bray
Diabetes Care Jan 2013, 36 (1) 11-12; DOI: 10.2337/dc12-1631

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Potential Health Risks From Beverages Containing Fructose Found in Sugar or High-Fructose Corn Syrup
George A. Bray
Diabetes Care Jan 2013, 36 (1) 11-12; DOI: 10.2337/dc12-1631
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Background
    • Brief overview
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • How Valid Are the New Hypoglycemia Definitions for Use in Clinical Trials?
  • Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
  • The Cardiovascular Legacy of Good Glycemic Control: Clues About Mediators From the DCCT/EDIC Study
Show more Commentary

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.